FT. LEE, N.J.--(BUSINESS WIRE)--Karen Bien, director, Business Technology, in Pfizer’s Acquisition, Collaboration and Divestiture team, has been elected to the board of directors of SAFE-BioPharma Association, the strategic non-profit collaboration that developed and manages the global SAFE-BioPharma® digital identity and digital signature standard for the life science and healthcare sectors. The association’s members include most of the world’s largest biopharmaceutical companies.
